APA (7th ed.) Citation

M, C., R, A., AF, M., T, A., D, F., J, F., . . . DD, P. (2026). Non-cytolytic re-engineering of a viral vaccine vector enables durable effector-memory T cell immunity by reinforcing type I IFN induction. Molecular therapy. Nucleic acids, 37(1), 102852. https://doi.org/10.1016/j.omtn.2026.102852

Chicago Style (17th ed.) Citation

M, Ciancaglini, et al. "Non-cytolytic Re-engineering of a Viral Vaccine Vector Enables Durable Effector-memory T Cell Immunity by Reinforcing Type I IFN Induction." Molecular Therapy. Nucleic Acids 37, no. 1 (2026): 102852. https://doi.org/10.1016/j.omtn.2026.102852.

MLA (9th ed.) Citation

M, Ciancaglini, et al. "Non-cytolytic Re-engineering of a Viral Vaccine Vector Enables Durable Effector-memory T Cell Immunity by Reinforcing Type I IFN Induction." Molecular Therapy. Nucleic Acids, vol. 37, no. 1, 2026, p. 102852, https://doi.org/10.1016/j.omtn.2026.102852.